Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shôn Lewis

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Pilot and Feasibility Studies|April 12, 2025
Digital Assessment of Wellbeing in New Parents (DAWN-P): protocol of a randomised feasibility trial comparing digital screening for maternal postnatal depression with usual care screeningEmily Eisner, Ria Agass, Elizabeth Camacho, et al.
Pilot and Feasibility Studies|December 15, 2016
Culturally-adapted Family Intervention (CaFI) for African-Caribbeans diagnosed with schizophrenia and their families: a feasibility study protocol of implementation and acceptabilityDawn Edge, Amy Degnan, Sarah Cotterill, et al.
Studies in Health Technology and Informatics|August 12, 2015
Mobile early detection and connected intervention to coproduce better care in severe mental illnessPauline Whelan, Matthew Machin, Shôn Lewis, et al.
Archives of General Psychiatry|March 3, 2010
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis studyStephan Ruhrmann, Frauke Schultze-Lutter, Raimo K R Salokangas, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 3, 2004
Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trialNicholas Tarrier, Shôn Lewis, Gillian Haddock, et al.
NPJ Schizophrenia|August 3, 2019
Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamateKate Merritt, Rocio Perez-Iglesias, Kyra-Verena Sendt, et al.
Focus (American Psychiatric Publishing)|January 31, 2020
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching AntipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
BMJ Open|November 26, 2021
Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA studyEdward Millgate, Eugenia Kravariti, Alice Egerton, et al.
Schizophrenia Bulletin|March 20, 2015
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Psychological Medicine|February 18, 2022
Cognitive function in early-phase schizophrenia-spectrum disorder: IQ subtypes, brain volume and immune markersAndrew J Watson, Annalisa Giordano, John Suckling, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Pilot and Feasibility Studies|April 12, 2025
Digital Assessment of Wellbeing in New Parents (DAWN-P): protocol of a randomised feasibility trial comparing digital screening for maternal postnatal depression with usual care screeningEmily Eisner, Ria Agass, Elizabeth Camacho, et al.
Pilot and Feasibility Studies|December 15, 2016
Culturally-adapted Family Intervention (CaFI) for African-Caribbeans diagnosed with schizophrenia and their families: a feasibility study protocol of implementation and acceptabilityDawn Edge, Amy Degnan, Sarah Cotterill, et al.
Studies in Health Technology and Informatics|August 12, 2015
Mobile early detection and connected intervention to coproduce better care in severe mental illnessPauline Whelan, Matthew Machin, Shôn Lewis, et al.
Archives of General Psychiatry|March 3, 2010
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis studyStephan Ruhrmann, Frauke Schultze-Lutter, Raimo K R Salokangas, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 3, 2004
Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trialNicholas Tarrier, Shôn Lewis, Gillian Haddock, et al.
NPJ Schizophrenia|August 3, 2019
Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamateKate Merritt, Rocio Perez-Iglesias, Kyra-Verena Sendt, et al.
Focus (American Psychiatric Publishing)|January 31, 2020
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching AntipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
BMJ Open|November 26, 2021
Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA studyEdward Millgate, Eugenia Kravariti, Alice Egerton, et al.
Schizophrenia Bulletin|March 20, 2015
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Psychological Medicine|February 18, 2022
Cognitive function in early-phase schizophrenia-spectrum disorder: IQ subtypes, brain volume and immune markersAndrew J Watson, Annalisa Giordano, John Suckling, et al.
Pageof 7